🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
32.10
+2.31 (7.75%)
Nov 19, 2026, 1:58 PM EST - Market open

UroGen Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
85.56110.75171.999555.4144.36
Short-Term Investments
4.999.7164.741.9744.5644.78
Cash & Short-Term Investments
90.55120.46236.69136.9799.9689.14
Cash Growth
-28.72%-49.11%72.80%37.02%12.14%-12.62%
Receivables
117.2833.0820.315.4412.711.72
Inventory
25.1516.469.235.674.334.83
Prepaid Expenses
17.5814.678.8510.2811.17.48
Restricted Cash
1.331.351.080.820.811.23
Total Current Assets
251.9186.02276.14169.19128.91114.39
Property, Plant & Equipment
7.949.093.792.363.753.15
Long-Term Investments
--5.024.5-0.68
Other Long-Term Assets
12.045.340.772.262.961.53
Total Assets
271.87200.46285.71178.31135.62119.75

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
17.2612.1410.936.515.535.79
Accrued Expenses
46.4729.127.0720.8415.1113.26
Current Portion of Leases
2.161.761.530.820.941.09
Other Current Liabilities
8.143.436.423.042.342.24
Total Current Liabilities
74.0346.4245.9531.2123.9222.38
Long-Term Debt
189.35122.21121.7398.5597.54-
Long-Term Leases
4.776.121.650.841.590.4
Other Long-Term Liabilities
128.94131.18125.18112.92101.9488.56
Total Liabilities
397.09305.93294.51243.52224.98111.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.130.120.090.060.06
Additional Paid-In Capital
873.75854.09797.25614.04487.79475.7
Retained Earnings
-999.1-959.72-806.22-679.35-577.1-467.32
Comprehensive Income & Other
-00.020.060.01-0.11-0.03
Total Common Equity
-125.22-105.47-8.8-65.21-89.368.41
Shareholders' Equity
-125.22-105.47-8.8-65.21-89.368.41
Total Liabilities & Equity
271.87200.46285.71178.31135.62119.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
196.28130.09124.92100.21100.061.49
Net Cash (Debt)
-105.73-9.63116.7941.26-0.188.33
Net Cash Growth
--183.09%---12.73%
Net Cash Per Share
-2.11-0.202.721.43-0.003.95
Filing Date Shares Outstanding
49.0548.6846.0934.1223.4422.67
Total Common Shares Outstanding
49.0348.3542.2332.4923.1322.46
Working Capital
177.87139.61230.19137.97104.9992.01
Book Value Per Share
-2.55-2.18-0.21-2.01-3.860.37
Tangible Book Value
-125.22-105.47-8.8-65.21-89.368.41
Tangible Book Value Per Share
-2.55-2.18-0.21-2.01-3.860.37
Machinery
4.784.64.314.023.833.58
Leasehold Improvements
0.630.630.630.620.620.62
SEC Filings: 10-K · 10-Q